Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biomea Fusion, Inc.

1.91
-0.9900-34.14%
Post-market: 1.940.0300+1.57%19:59 EDT
Volume:11.66M
Turnover:23.43M
Market Cap:71.76M
PE:-0.54
High:2.23
Open:2.06
Low:1.84
Close:2.90
Loading ...
OverviewCompanyNewsFilings

Biomea Fusion to become diabetes, obesity medicines company

TIPRANKS
·
13 Jan

Biomea Fusion Inc: Plans to Conclude Its Studies Exploring Icovamenib's Potential in Oncology

THOMSON REUTERS
·
13 Jan

Biomea Fusion to Become a Diabetes & Obesity Medicines Company

THOMSON REUTERS
·
13 Jan

Biomea Fusion: Based on Most Recent Trial Results, Strategic Focus for Icovamenib Will Be in Metabolic Disorders

THOMSON REUTERS
·
13 Jan

3 US Penny Stocks With Market Caps Up To $2B

Simply Wall St.
·
09 Jan

Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Biomea Fusion (BMEA) and Solid Biosciences (SLDB)

TIPRANKS
·
09 Jan

Scotiabank Sticks to Its Buy Rating for Biomea Fusion (BMEA)

TIPRANKS
·
08 Jan

Biomea Fusion reports new preclinical data on icovamenib-semaglutide study

TIPRANKS
·
07 Jan

Biomea Fusion Reports New Preclinical Data on Icovamenib-Semaglutide Combination Study

THOMSON REUTERS
·
07 Jan

Biomea Fusion Inc - Icovamenib With Semaglutide Shows 11.5% Body Weight Reduction

THOMSON REUTERS
·
07 Jan

Here’s Why Biomea Fusion, Inc. (NASDAQ:BMEA) Is Among the Best Diabetes Stocks to Buy Under $10

Insider Monkey
·
06 Jan

Analyst Rate

Buy
Buy
77.78%
Hold
22.22%
Sell
0.00%

Corporate Actions

Financial Report Announcement
May 05, 2025 Post Market
Financial Report Announcement
Mar 31, 2025 Post Market
Financial Report Announcement
Oct 29, 2024 Post Market
Financial Report Announcement
Jul 31, 2024 Post Market
Financial Report Announcement
May 02, 2024 Post Market

Dividend History

no data

No relevant data is available

Valuation Analysis

-1.29
Current
-9.88
Sector Average
87.21%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-1.29
Maximum
-0.42
+1 STD
6.99
Minimum
-97.88
-1 STD
-26.76
Average
-9.88

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.